麦克奥迪(300341) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥348,643,873.82, a decrease of 3.02% compared to ¥359,515,780.05 in the same period last year[4] - Net profit attributable to shareholders was ¥38,942,232.67, down 14.62% from ¥45,610,282.01 year-on-year[4] - Basic and diluted earnings per share decreased by 15.10% to ¥0.0759 from ¥0.0894 in the same period last year[4] - Total operating revenue for Q1 2023 was CNY 348,643,873.82, a decrease of 3.4% compared to CNY 359,515,780.05 in Q1 2022[17] - Net profit for Q1 2023 was CNY 40,564,635.86, down 14.6% from CNY 47,191,169.22 in Q1 2022[19] - Earnings per share for Q1 2023 were CNY 0.0759, compared to CNY 0.0894 in the same period last year, reflecting a decline of 15.6%[20] - The company recorded a comprehensive income of CNY 32,129,339.87 for Q1 2023, down from CNY 44,069,776.67 in the same period last year[20] Cash Flow - The net cash flow from operating activities increased significantly by 316.07% to ¥59,298,306.46, compared to ¥14,251,925.13 in the previous year[4] - The company reported a net increase in cash flow from operating activities due to increased collections from receivables in the medical segment[9] - The net cash flow from operating activities for Q1 2023 was ¥59,298,306.46, a significant increase from ¥14,251,925.13 in Q1 2022, representing a growth of approximately 317%[23] - Cash inflow from operating activities increased to CNY 420,542,720.06 in Q1 2023, up from CNY 340,370,457.92 in Q1 2022, representing a growth of 23.6%[22] - The company reported a total cash outflow from operating activities of ¥361,244,413.60, which is higher than ¥326,118,532.79 in the previous year, indicating increased operational expenses[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,231,418,082.18, a slight increase of 0.03% from ¥2,230,637,587.80 at the end of the previous year[4] - The company's equity attributable to shareholders increased by 2.36% to ¥1,591,989,303.98 from ¥1,555,240,324.80 at the end of the previous year[4] - Total liabilities as of Q1 2023 were CNY 506,217,833.55, down from CNY 538,857,604.09 in the previous year[19] - Current liabilities decreased to ¥473,065,289.90 from ¥505,000,513.29, a reduction of approximately 6.31%[15] - Non-current assets total ¥583,542,857.19, up from ¥574,666,106.22, indicating an increase of about 1.52%[15] Investments - The company’s investment activities generated a net cash outflow of ¥40,998,500, a decrease of 4,416,230 compared to the previous year, mainly due to investments in the renovation of the second phase of the factory[9] - Total cash outflow from investing activities was ¥41,001,003.82, compared to ¥17,288,954.07 in the previous year, indicating a year-over-year increase of about 137.5%[23] - The net cash flow from investing activities was -¥40,998,482.71, a decline from a positive cash flow of ¥3,163,795.93 in Q1 2022[23] Shareholder Information - Total number of common stock shareholders at the end of the reporting period is 21,520[11] - The largest shareholder, Beijing Yizhuang Investment Holding Co., Ltd., holds 29.80% of shares, totaling 152,997,984 shares[11] Other Financial Metrics - The company experienced a decrease in financial expenses by ¥6,222,400, primarily due to the impact of the continuous depreciation of the RMB[8] - The company has a long-term investment of ¥3,428,447.14, down from ¥3,667,581.63, a decrease of approximately 6.53%[15] - Research and development expenses for Q1 2023 were CNY 14,379,974.40, a decrease of 6.4% from CNY 15,361,562.74 in Q1 2022[17] - The company reported a financial expense of CNY -3,515,470.42 in Q1 2023, a significant improvement compared to CNY 2,706,932.75 in Q1 2022[19] - The cash inflow from other financing activities was ¥855,000.00, a decrease from ¥1,400,000.00 in Q1 2022, indicating a reduction in external financing sources[23] Strategic Initiatives - The company is actively exploring new product development and market expansion strategies, although specific details were not disclosed in the report[12] Audit Information - The company did not conduct an audit for the Q1 2023 report, as stated in the audit report[24]